Brain tumors is one of the leading cause of cancer which is common among children and teenagers. Glioblastoma (GBM) is most common grade four tumor, is malignant and contains dead tumor cells. It is also called as Glioblastoma multiforme, it has variants of giant cell Glioblastoma and gliosarcoma found in cerebral hemisphere of brain. The exact cause of this tumor is not known but is also found in spinal cord and represents about 15.4% of all primary brain tumors. Glioblastoma is also difficult to treat because of number of different types of cells and thus combines various treatment plans combined. The drugs involved in treating glioblastoma are antineoplastic orcytotoxic drugs. There is significant development in chemotherapy drugs to treat the malignant tumors and each year there are new drugs in the market to overcome the blood-brain barrier. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1248

1. Glioblastoma Treatment Drugs Market Globally Expected
to Drive Growth through 2026
November 2016
©2015 Future Market Insights, All Rights Reserved
Report Id : REP-GB-1248
Status : Ongoing
Category : Healthcare, Pharmaceuticals & Medical Devices

2. About
Future Market Insights
©2015 Future Market Insights, All Rights Reserved
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Subscription Information
 Customized Research
 Syndicated Research
 Investment Research
 Social Media Research
Sector Coverage
 Automotive and Transportation
 Electronics, Semiconductor, and ICT
 Retail and Consumer Products
 Industrial Automation and Equipment
 Chemicals & Materials
 Food and Beverages
 Services and Utilities
 Energy, Mining, Oil, and Gas
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
2

3. Research Methodology (1/2)
Systematic Research Approach
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
(PDF)
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
A
C
B
Primary
Research
Company
Analysis
Desk
Research
 Identifying key opinion leaders
 Questionnaire design
 In-depth interviews
 Coverage across value chain
 Market participants
 Key strengths
 Product portfolio
 Mapping as per value chain
 Key focus segments
 Key industry experts
 Channel study
 Developments
 Market dynamics
 Products
 Conclusions
SOLUTION
Primary Research#
 Linkedin
 Zoominfo
 Salesforce
 Avention
 Factiva
 GBI
 Genios
 Meltwater
 Company websites
 Company annual
reports
 White papers
 Financial reports
©2015 Future Market Insights, All Rights Reserved
Secondary Research # Paid Publications#
Insights
Market profiling
Formulating discussion guide
Developing list of respondents
Data analysis
Data validation
Data collection
1
2
3
4
5
6
7
# includes sources of databases
3

4. Glioblastoma Treatment Drugs Market Globally Expected to Drive Growth through 2026
Brain tumors is one of the leading cause of cancer which is common among children and teenagers.
Glioblastoma (GBM) is most common grade four tumor, is malignant and contains dead tumor cells. It is
also called as Glioblastoma multiforme, it has variants of giant cell Glioblastoma and gliosarcoma found in
cerebral hemisphere of brain. The exact cause of this tumor is not known but is also found in spinal cord
and represents about 15.4% of all primary brain tumors. Glioblastoma is also difficult to treat because of
number of different types of cells and thus combines various treatment plans combined. The drugs
involved in treating glioblastoma are antineoplastic orcytotoxic drugs. There is significant development in
chemotherapy drugs to treat the malignant tumors and each year there are new drugs in the market to
overcome the blood-brain barrier.
Glioblastoma Treatment Drugs Market: Drivers & Restraints
Glioblastoma is a complicated disease and thus the treatment for it involves various approaches
combining various treatments which is the major market driver for Glioblastoma treatment drugs market.
Treating such tumors is a challenge which forces the researchers to look for diagnosis and newer
chemotherapy drugs. Changing demography, access to healthcare facilities and financial demands are
some factors which are lagging in the further developments of glioblastoma. Gaining better
understanding of this disease and efficient treatment will improvise which is only possible through
developments in molecular mechanisms, clinical trials leading to more promising and tailored therapeutic
approaches.
Glioblastoma Treatment Drugs Market
©2015 Future Market Insights, All Rights Reserved 4

5. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1248
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1248
Glioblastoma Treatment Drugs Market: Segmentation
The Glioblastoma treatment drugs market can be segmented on the basis of drug class and distribution
channel.
Based on the drug class the Glioblastoma treatment drugs market can be segmented into following:
Antineoplastic
VEGF/VEGFR Inhibitors
Alkylating Agents
Miscellaneous Antineoplastic
Glioblastoma Treatment Drugs Market
©2015 Future Market Insights, All Rights Reserved 5
Click here to
Order a free sample

6. Based on the distribution channel the glioblastoma treatment drug market can be segmented into
following:
Hospitals
Cancer Research Organizations
Long Term Care Centers
Diagnostic Centers
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1248
Glioblastoma Treatment DrugsMarket: Overview
The market for Glioblastoma treatment drugs will grow significantly as the increasing cases of
glioblastoma where doctors are looking for newer drugs and treatment methods to overcome the
Glioblastoma Treatment Drugs Market
©2015 Future Market Insights, All Rights Reserved 6

7. disease. ‘Quality of life’ has become an essential factor in the survival of cancer patients which is driving
the market for new drug development methods with different approaches. It is a leading cause of cancer
in children and males it is mostly encountered in the developed economies as U.S, U.K and Asian
countries. There are various organizations which are supporting Glioblastoma patients and efforts are
being taken to improvise the treatments related to it.
Glioblastoma Treatment DrugsMarket: Region-wise Outlook
Worldwide, there are an estimated 240,000 cases related to brain cancer and Glioblastoma is most
common and lethal disease. Every year in U.S there are about 18000 people diagnosed with GBM and in
European countries 25000 cases therefore there is prime incidences of this disease. More treatments are
coming forward which can be used alone or in combination with radiotherapy and chemotherapy, but
there are chances of reappearance. For long term survival of in glioblastoma, there are newer
combination therapies studied and various clinical trials are in order to fight against these disease.
Glioblastoma TreatmentDrugs Market: Key Players
The key players for the Glioblastoma Treatment Drugs Market are F. Hoffmann-La Roche AG, Merck &
Co., Inc., Sandoz, Arbor Pharms LLC., Emcure Pharmaceuticals Ltd., Bristol-Myers Squibb Company and
Sigma-Tau Pharmaceuticals, Inc.
Glioblastoma Treatment Drugs Market
©2015 Future Market Insights, All Rights Reserved 7

8. ©2015 Future Market Insights, All Rights Reserved
Future Market Insights Global & Consulting Private Limited (FMI)
Thank You
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For media queries, contact the press office at
press@futuremarketinsights.com
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
8